Events Archive

Please join ITIF for an expert panel discussion about the merits and implications of the DOJ’s lawsuit against Apple.

Please join ITIF as it launches the Centre for Canadian Innovation and Competitiveness, an Ottawa-based ITIF affiliate focused on tackling these issues. This event will feature an expert panel discussion on a new report from the Centre examining the how and why of Canada’s performance on key measures of productivity, innovation, and competitiveness.

Watch now for a panel discussion to explore the current landscape of AI applications in transitioning to a greener economy, identify key areas ripe for further exploration, and discuss actionable policy measures to foster innovation and adoption.

Watch now for a panel discussion featuring experts from the EU, Brazil, Korea, and the United States.

Watch now for a panel discussion exploring the hurdles impeding the widespread adoption of AI in the public sector and examining actionable steps to empower and facilitate the sector in harnessing the benefits of this cutting-edge technology.

Please join ITIF for an expert panel discussion about a new report examining the role of federal funding for clean energy research conducted by colleges and universities.

Watch now for an ITIF discussion alongside experts and stakeholders who will provide context and perspectives for the state of U.S. spectrum policy and discuss how we can increase the productivity of scarce spectrum resources.

Watch now for an expert panel discussion of Europe’s efforts and the implications for an allied approach to economic security in an era of economic warfare.

Watch now for a high-level panel discussion featuring Signe Ratso, deputy director-general for research and innovation at the European Commission; Erwin Gianchandani, assistant director of NSF’s TIP Directorate; Meg Hardon of Infineon Technologies; and Paul Sweetman of the American Chamber of Commerce Ireland.

Watch now for an expert panel discussion surrounding the ITIF report examining why the United States lost its lead in other advanced technology industries, and how policymakers can avoid repeating the same mistakes in the biopharmaceutical sector.